Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed High Risk Neuroblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)UnknownNCT00281905
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Children's Cancer and Leukaemia Group 50
Early research (Phase 1)Study completedNCT01175356
What this trial is testing

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 99
Early research (Phase 1)Not Yet RecruitingNCT07688252
What this trial is testing

Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma

Who this might be right for
High Risk Neuroblastoma
Chang Gung Memorial Hospital 30
Early research (Phase 1)Looking for participantsNCT06485947
What this trial is testing

Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma

Who this might be right for
Neuroblastoma
Princess Maxima Center for Pediatric Oncology 38
Not applicableWithdrawnNCT06335745
What this trial is testing

PediCARE Health Equity Intervention in High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaHigh-risk NeuroblastomaPediatric Cancer+3 more
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT05489887
What this trial is testing

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Giselle Sholler 93
Not applicableLooking for participantsNCT06831552
What this trial is testing

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaHigh-risk Neuroblastoma
Dana-Farber Cancer Institute 84
Testing effectiveness (Phase 2)Study completedNCT00017368
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Oncology Group 42
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Not applicableWithdrawnNCT00624962
What this trial is testing

Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLeukemia+4 more
Vanderbilt University